Breaking News on Global Pharmaceutical Technology & Manufacturing

Headlines > Ingredients

News in brief

EMA seeks feedback on non-EU API import confirmation letter

Last updated on 18-Apr-2012 at 09:35 GMT

The EMA is seeking industry comments on its draft template for written confirmation of API imports from outside Europe.

Publication of the draft follows adoption of the falsified medicines directive. The directive says firms should only import APIs (active pharmaceutical ingredients) from overseas after the regulator in the country of manufacture sends written confirmation that the plant meets European Union standards.

To help firms gain confirmation the European Medicines Agency (EMA) has posted a draft template showing what information is needed. Companies have until June 1 to comment on the template.

Subscribe to our FREE newsletter

Get FREE access to authoritative breaking news, videos, podcasts, webinars and white papers. SUBSCRIBE

Key Industry Events


Access all events listing

Our events, Events from partners...